14 | AcidsIBA
11/2018
-
10/2004 |
10 | Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2013
-
12/2004 |
9 | Arachidonic Acid (Vitamin F)IBA
06/2010
-
01/2002 |
7 | 14,15-epoxy-5,8,11-eicosatrienoic acidIBA
11/2018
-
10/2005 |
5 | glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA
02/2011
-
12/2004 |
5 | 20-hydroxy-5,8,11,14-eicosatetraenoic acidIBA
01/2007
-
10/2004 |
4 | 11,12-epoxy-5,8,14-eicosatrienoic acidIBA
06/2013
-
08/2006 |
4 | Adenosine Triphosphate (ATP)IBA
01/2012
-
12/2004 |
4 | EndocannabinoidsIBA
02/2011
-
12/2004 |
3 | EnzymesIBA
11/2018
-
01/2007 |
3 | KATP ChannelsIBA
02/2012
-
12/2004 |
3 | HMR 1098IBA
01/2012
-
12/2004 |
3 | cytochrome P-450 omega-hydroxylaseIBA
03/2009
-
12/2004 |
3 | AndrogensIBA
09/2007
-
12/2004 |
3 | Mixed Function Oxygenases (Monooxygenases)IBA
02/2006
-
10/2004 |
3 | DDMSIBA
02/2006
-
10/2004 |
2 | Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
06/2013
-
02/2012 |
2 | Barbital (Barbitone)IBA
01/2012
-
06/2008 |
2 | Ether (Diethyl Ether)IBA
02/2011
-
01/2010 |
2 | Phospholipases (Phospholipase)IBA
01/2007
-
10/2005 |
2 | Vasoconstrictor AgentsIBA
01/2007
-
10/2005 |
2 | Fatty Acids (Saturated Fatty Acids)IBA
01/2007
-
02/2004 |
2 | Miconazole (Monistat)FDA LinkGeneric
12/2004
-
10/2004 |
2 | Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2004
-
01/2002 |
2 | ProstaglandinsIBA
01/2004
-
01/2002 |
2 | Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
01/2004
-
01/2002 |
1 | EET-BIBA
11/2018 |
1 | Prolyl Hydroxylases (Prolyl Hydroxylase)IBA
11/2018 |
1 | Cyclosporine (Ciclosporin)FDA LinkGeneric
06/2013 |
1 | 1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
06/2013 |
1 | Mitochondrial Permeability Transition PoreIBA
06/2013 |
1 | Opioid Receptors (Opioid Receptor)IBA
02/2012 |
1 | Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
02/2012 |
1 | eribis peptide 94IBA
02/2012 |
1 | Cannabinoid Receptors (Cannabinoid Receptor)IBA
01/2012 |
1 | Monomeric GTP-Binding ProteinsIBA
01/2012 |
1 | Purinergic P1 Receptors (Adenosine Receptor)IBA
01/2012 |
1 | Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2012 |
1 | Bradykinin Receptors (Bradykinin Receptor)IBA
12/2011 |
1 | BradykininIBA
12/2011 |
1 | anandamide (arachidonylethanolamide)IBA
02/2011 |
1 | noladin etherIBA
02/2011 |
1 | Cytochrome P-450 CYP2C8IBA
12/2010 |
1 | Messenger RNA (mRNA)IBA
12/2010 |
1 | Proteins (Proteins, Gene)FDA Link
12/2010 |
1 | Pertussis ToxinIBA
06/2010 |
1 | AngiotensinsIBA
01/2010 |
1 | EstersIBA
03/2009 |
1 | fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA
09/2008 |
1 | EicosanoidsIBA
08/2008 |
1 | Epoxide HydrolasesIBA
06/2008 |
1 | Arachidonate 12-Lipoxygenase (12 Lipoxygenase)IBA
09/2007 |
1 | 8,9-epoxyeicosatrienoic acidIBA
03/2007 |
1 | Reactive Oxygen Species (Oxygen Radicals)IBA
03/2007 |
1 | mitochondrial K(ATP) channelIBA
03/2007 |
1 | Vasodilator Agents (Vasodilators)IBA
01/2007 |
1 | Hydroxyeicosatetraenoic Acids (HETE)IBA
02/2006 |
1 | 20-hydroxyeicosa-6(Z),15(Z)-dienoic acidIBA
02/2006 |
1 | Phospholipases A2 (Phospholipase A2)IBA
10/2005 |
1 | Carboxylic Ester HydrolasesIBA
07/2005 |
1 | KetonesIBA
07/2005 |
1 | CB1 Cannabinoid Receptor (CB1 Receptor)IBA
12/2004 |
1 | Cytochrome P-450 CYP4A (Alkane 1 Monooxygenase)IBA
12/2004 |
1 | 17-octadecynoic acidIBA
12/2004 |
1 | N- methylsulfonyl- 6- (2- propargyloxyphenyl)hexanamideIBA
12/2004 |
1 | 5-hydroxydecanoic acidIBA
12/2004 |
1 | CytochromesIBA
10/2004 |
1 | Linoleic Acid (Linoleate)IBA
02/2004 |
1 | SteroidsIBA
02/2004 |
1 | Indomethacin (Indometacin)FDA LinkGeneric
01/2004 |
1 | Prostaglandins EIBA
01/2004 |
1 | Celecoxib (Celebrex)FDA Link
01/2004 |
1 | G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2004 |
1 | baicaleinIBA
04/2003 |
1 | phenidoneIBA
04/2003 |
1 | 12-Hydroxy-5,8,10,14-eicosatetraenoic AcidIBA
04/2003 |